Researchers from the University of Exeter in conjunction with King’s College London and Oxford Health NHS Foundation Trust aimed to evaluate the efficacy of person-centred care and psychosocial intervention incorporating an antipsychotic review on 800 patients with dementia.
The study tested the WHELD programme, (Improving Wellbeing and Health for People with Dementia), the largest non-pharmacological randomised control trial in people with dementia living in care homes to date.
- The programme combined staff training, social interaction, and guidance on use of antipsychotic medications, in 69 UK care homes in a 9-month clinical trial.
- It demonstrates that care homes receiving the WHELD programme saw improvements in quality of life as well as other important symptoms including agitation, behaviour, and pain in people with dementia.
- For the care homes in the study, the WHELD programme was also shown to be cost-effective
The key findings include:
- The WHELD approach is beneficial for people with dementia living in care homes.
- WHELD could be provided in an affordable way to improve the lives of these individuals, who often do not receive the care they need.
- They also suggest suggest that the WHELD intervention confers benefits in terms of quality of life (QoL), agitation, and neuropsychiatric symptoms, albeit with relatively small effect sizes,
The full text article can be accessed through the PLOS Medicine website
Download it from PLOS here
The full story is at Science Daily